|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.820 USD | -0.26% |
|
+28.41% | -44.89% |
| 09-04 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 35.79M | - | - | - | - | - |
| 67.98B | |||||
| 64.94B | |||||
| 27.58B | - | ||||
| 26.06B | - | ||||
| 25.74B |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
